This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Medicines Company (MDCO)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -32.35M 15.26M 51.17M 127.88M
Operating Gains/Losses 1.75M 39.00K 69.00K 299.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -54.74M -14.67M -11.09M -27.18M
(Increase) Decrease in Inventories 5.63M -10.13M -31.15M -19.79M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -6.87M -1.32M 18.90M -2.20M
(Decrease) Increase In Other Current Liabilities 24.06M 31.19M -40.16M 71.73M
(Increase) Decrease In Other Working Capital 8.65M 5.19M 1.42M 171.00K
Other Non-Cash Items 83.99M 32.49M 11.39M -2.77M
Net Cash From Continuing Operations 67.31M 91.42M 46.35M 96.38M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 67.31M 91.42M 46.35M 96.38M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 50.66M 38.88M 126.71M
Purchases of Property, Plant & Equipment -22.29M -13.57M -37.68M -8.27M
Acquisitions -58.93M -542.58M 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 -65.35M -33.58M
Other Cash from Investing Activities -3.53M 1.14M 3.15M -6.45M
Cash Provided by Financing Activities
Net Cash From Investing Activities -84.76M -504.36M -63.51M 78.41M
Issuance of Debt 0.00 0.00 216.78M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 17.34M 74.21M 61.36M 6.72M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 -50.00M 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -8.51M 197.28M -7.22M 9.39M
Net Cash From Financing Activities 8.83M 271.49M 220.92M 16.12M
Effect of Exchange Rate Changes 2.62M -1.26M 305.00K -1.89M
Net Change in Cash & Cash Equivalents -5.99M -142.72M 204.06M 189.02M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

MDCO The Medicines Company

Chart of MDCO

Analysts Ratings for MDCO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 4 3
Moderate Buy 1 1 1 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

MDCO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs